Page last updated: 2024-08-23

sq-11725 and Neurally Mediated Faint

sq-11725 has been researched along with Neurally Mediated Faint in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flevari, P; Kremastinos, DT; Livanis, EG; Mesiskli, T; Theodorakis, GN; Zarvalis, E	1
Krist, A; Phillips, J	1

Trials

2 trial(s) available for sq-11725 and Neurally Mediated Faint

Article	Year
Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. Journal of the American College of Cardiology, 2002, Aug-07, Volume: 40, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Nadolol; Propranolol; Prospective Studies; Recurrence; Syncope, Vasovagal; Treatment Outcome	2002
Beta-blockers no better than placebo in the treatment of vasovagal syncope. The Journal of family practice, 2002, Volume: 51, Issue:11 Topics: Adrenergic beta-Antagonists; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nadolol; Probability; Prognosis; Propranolol; Prospective Studies; Reference Values; Severity of Illness Index; Syncope, Vasovagal; Treatment Outcome	2002

Article

Year

Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.

Journal of the American College of Cardiology, 2002, Aug-07, Volume: 40, Issue:3

Topics: Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Female; Follow-Up Studies; Humans; Male; Nadolol; Propranolol; Prospective Studies; Recurrence; Syncope, Vasovagal; Treatment Outcome

2002

Beta-blockers no better than placebo in the treatment of vasovagal syncope.

The Journal of family practice, 2002, Volume: 51, Issue:11

Topics: Adrenergic beta-Antagonists; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nadolol; Probability; Prognosis; Propranolol; Prospective Studies; Reference Values; Severity of Illness Index; Syncope, Vasovagal; Treatment Outcome

2002